Stimvia is a rising medical device company currently conducting clinical trials for a novel technology that enables safe, effective and non-invasive delivery of neuromodulation …

Stimvia je společnost ve fázi klinického testování své nové unikátní technologie, která umožňuje bezpečnou, efektivní a neinvazivní léčbu prostřednictvím neuromodulace. Využíváme …

At Stimvia, we transcend conventional neuromodulation therapy by integrating the prowess of advanced AI with the precise data capture of the URIS device. Our unique approach pivots on …

PRAGUE, June 7, 2024 /PRNewswire/ -- Stimvia, a pioneering medical technology company specializing in neuromodulation for chronic disease treatment, has successfully completed its …

Nov 14, 2023 · A pilot trial into whether deep brain stimulation based on noninvasive neuromodulation of a lower leg nerve can safely and effectively ease symptoms of Parkinson’s …

PRAGUE, Nov. 8, 2023 /PRNewswire/ -- Stimvia, a company specializing in the use of neuromodulation for the treatment of chronic diseases, successfully completed recruitment for …

PRAGUE, March 21, 2023 /PRNewswire/ -- STIMVIA a pioneer medical technology company focused on the development and commercialization of novel non-invasive neuromodulation for …

Jun 10, 2024 · Stimvia has announced initial positive results from its pilot study for a new add-on treatment for patients with Parkinson's disease (PD).

Nov 8, 2023 · Stimvia announced today that it completed enrollment in a study of neuromodulation for treating Parkinson’s disease and essential tremor. The study evaluates …

Jun 7, 2024 · Stimvia, a pioneering medical technology company specializing in neuromodulation for chronic disease treatment, has successfully completed its pilot study focused on …